• About Us
  • Contact Us
  • Submit News Release
Friday, April 17, 2026
No Result
View All Result
submit news
Oman News Club
  • BUSINESS
  • ENERGY
  • FINANCE
  • HEALTHCARE
  • LIFESTYLE
  • REAL ESTATE
  • TECH
  • TRAVEL
  • MIDDLE EAST
  • PRESS RELEASES
  • BUSINESS
  • ENERGY
  • FINANCE
  • HEALTHCARE
  • LIFESTYLE
  • REAL ESTATE
  • TECH
  • TRAVEL
  • MIDDLE EAST
  • PRESS RELEASES
No Result
View All Result
Oman News Club
Submit PR
Home PRESS RELEASES

Nucleotide Sugar Synthesis Services Market Strategic Insights Investment in Biopharmaceutical R&D and Academic Research

by Newsroom Editor
November 18, 2025
Share on FacebookShare on Twitter


InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Nucleotide Sugar Synthesis Services Market Size, Share & Trends Analysis Report By Type (Small-Scale Synthesis, Medium-Scale Synthesis, and Large-Scale Synthesis), Product Type (Uridine Diphosphate (UDP) Sugars, Cytidine Monophosphate (CMP) Sugars, Guanosine Diphosphate (GDP) Sugars, and Others), Application (Vaccine Preparation, Drug Research & Development (R&D), Genetic Engineering and Cell Therapy, Diagnostics, and Academic Research),-Market Outlook And Industry Analysis 2034″

Global Nucleotide Sugar Synthesis Services Market Size is valued at US$ 440.0 Mn in 2024 and is predicted to reach US$ 1,306.2 Mn by the year 2034 at an 11.7% CAGR during the forecast period for 2025-2034.

 

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/3275

 

The biotechnology and pharmaceutical sectors depend heavily on the nucleotide sugar synthesis services market, which supplies vital elements for glycobiology research and treatment development. Nucleotide sugars are essential building blocks for the manufacture of glycoconjugates, which are essential for many biological functions, such as immunological responses and cell signaling. The synthesis of nucleotide sugars has become increasingly important as the need for glycan analysis and manipulation grows, especially in the development of monoclonal antibodies and vaccine research.

The nucleotide sugar synthesis services market is driven by the pharmaceutical and biotechnology sectors’ increasing demand for nucleotide sugars, particularly for the manufacturing of viral vectors for gene therapy and antibody-drug conjugates (ADCs). Moreover, the nucleotide sugar synthesis services market is primarily driven by advances in glycobiology research, the rising incidence of chronic illnesses, and the growing adoption of personalized treatment. Additionally, it is anticipated that the trend of outsourcing difficult synthesis processes to specialist suppliers will drive market expansion.

List of Prominent Players in the Nucleotide Sugar Synthesis Services Market:

  • CD BioGlyco
  • Creative Biolabs
  • Jena Bioscience GmbH
  • GenScript Biotech Corporation
  • Peptide Institute, Inc.
  • Eversyn Technologies
  • Oxeltis
  • BOC Sciences
  • Tokyo Future Style, Inc.
  • FUJIMOTO CHEMICALS CO., LTD
  • Thermo Fisher Scientific
  • Merck KGaA
  • Agilent Technologies
  • Eurofins Scientific
  • Twist Bioscience

 

Read Overview Report– https://www.insightaceanalytic.com/report/nucleotide-sugar-synthesis-services-market/3275

 

Market Dynamics:

Drivers-

The growing awareness of the critical role glycosylation plays in biological processes, the developing biopharmaceutical industry, and the growing need for individualized therapy are the main factors driving the growth of the nucleotide sugar synthesis services market. The market is expanding as the number of clinical trials focusing on glycoconjugate-based medicines increases.

Nucleotide sugar synthesis is becoming more affordable and accessible thanks to advances in high-throughput screening and automated synthetic chemistry. This encourages broader application across numerous research and development projects. Additionally, the nucleotide sugar synthesis services market has grown as investment in medication discovery and development programs targeting glycoproteins and glycans has increased, driven by the rising prevalence of chronic diseases globally.

Challenges:

The nucleotide sugar synthesis services market faces several obstacles despite its encouraging trajectory. For small- and medium-sized businesses, the high operating costs of bespoke synthesis pose a challenge, especially for rare or unstable nucleotide sugars. Significant infrastructure and quality assurance procedures are needed for GMP-grade nucleotide sugar manufacturing to comply with regulations. Additionally, the nucleotide sugar synthesis services market growth may also be hampered by low awareness in developing markets and a lack of specialized technical knowledge. Slower adoption in areas with limited resources is partly due to the high cost of procuring enzymes and the need for rigorous analytical validation.

Regional Trends:

The nucleotide sugar synthesis services market was dominated by the North American region in 2024, driven by the presence of major pharmaceutical and biotechnology firms developing drugs and vaccines. The need for tailored nucleotide sugars is largely driven by this region’s well-established research infrastructure and substantial funding for biological research. Due to a strong concentration of biotech companies, academic institutions, and service providers that specialize in glycobiology, the United States leads the region. Additionally, macroeconomic factors, including higher healthcare R&D spending, government support for life sciences, and favorable patent regimes for innovative biosynthetic processes, influence demand in North America.

The nucleotide sugar synthesis services market is expanding at the fastest rate in the Asia Pacific over the forecast period, driven by growing biotech research, expanding medicinal applications, and developing partnerships between CROs and academic institutions. Glycomics research, which uses nucleotide sugars in drug discovery and vaccine development, is receiving significant funding from countries such as China and India.

Additionally, the region’s cost-competitive environment and highly qualified workforce enhance its appeal for providing services globally. China has the largest market share in Asia Pacific due to significant government incentives, rapid expansion of glycoscience R&D, and the presence of sizable bioscience clusters. Moreover, a sizable market for glycosylation-related services is growing as the Asia Pacific transitions to customized medicine and cell-based therapies.

 

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customization/3275

 

Recent Developments:

  • June 2025: The clinical-stage biotech business CureVac, which is creating a revolutionary class of transformative therapies based on messenger ribonucleic acid (mRNA), has agreed to sell all of its shares to BioNTech.
  • March 2023: The opening of its new GMP-compliant production facility in the Netherlands was announced by GlycoEra, a significant participant in the nucleotide sugar synthesis services market. With the help of this facility, the business will be able to manufacture superior nucleotide sugars for use in the manufacturing of biopharmaceuticals and other medical products.
  • February 2023: In order to create and promote novel nucleotide sugar therapies for the treatment of uncommon genetic illnesses, Enzymatica, a significant participant in the nucleotide sugar synthesis services market, teamed up with Lonza, a global leader in the life sciences industry.

Segmentation of Nucleotide Sugar Synthesis Services Market-

By Type-

  • Small-Scale Synthesis
  • Medium-Scale Synthesis
  • Large-Scale Synthesis

By Product Type –

  • Uridine Diphosphate (UDP) Sugars
  • Cytidine Monophosphate (CMP) Sugars
  • Guanosine Diphosphate (GDP) Sugars
  • Others

By Application-

  • Vaccine Preparation
  • Drug Research & Development (R&D)
  • Genetic Engineering and Cell Therapy
  • Diagnostics
  • Academic Research

By Region-

North America-

  • The US
  • Canada

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:

InsightAce Analytic Pvt. Ltd.

Visit: https://www.insightaceanalytic.com/

Tel : +1 607 400-7072

Asia: +91 79 72967118

info@insightaceanalytic.com



Source link

Tags: #Glycobiology#NucleotideSugar#SugarSynthesis
Previous Post

Flame Retardants for Engineering Resins Market Drivers Challenges and Opportunities in Electrical Automotive and Construction Industries

Next Post

Engineered Enzymes Market Future Prospects Growth Potential and Investment Opportunities

Next Post
Automotive Garage Equipment Market to Reach USD 10.66 Billion by 2030, Fueled by Emissions Rules & EV Workshop Tools Trends – Mordor Intelligence

Automotive Garage Equipment Market to Reach USD 10.66 Billion by 2030, Fueled by Emissions Rules & EV Workshop Tools Trends – Mordor Intelligence

No Result
View All Result

Categories

  • BUSINESS (111)
  • ENERGY (119)
  • FINANCE (118)
  • HEALTHCARE (119)
  • LIFESTYLE (121)
  • MIDDLE EAST (680)
  • PRESS RELEASES (3,565)
  • REAL ESTATE (116)
  • TECH (104)
  • TRAVEL (21)
  • Uncategorized (4)

Recent.

$25 Billion by 2035 — How Generative AI Is Transforming Intelligent Virtual Assistants into Proactive Agents

$25 Billion by 2035 — How Generative AI Is Transforming Intelligent Virtual Assistants into Proactive Agents

April 17, 2026
$25 Billion by 2035 — How AI-Powered Sales Engagement Is Revolutionizing Revenue Operations

$25 Billion by 2035 — How AI-Powered Sales Engagement Is Revolutionizing Revenue Operations

April 17, 2026
$50 Billion by 2035 — How RaaS Is Democratizing Automation for Enterprises of All Sizes

$50 Billion by 2035 — How RaaS Is Democratizing Automation for Enterprises of All Sizes

April 17, 2026

Subscribe to our Newsletter

    Share Us

    Categories

    Categories
    • BUSINESS
    • ENERGY
    • FINANCE
    • HEALTHCARE
    • LIFESTYLE
    • MIDDLE EAST
    • PRESS RELEASES
    • REAL ESTATE
    • TECH
    • TRAVEL
    • Uncategorized

    Recent News

    Recent Posts
    • $25 Billion by 2035 — How Generative AI Is Transforming Intelligent Virtual Assistants into Proactive Agents
    • $25 Billion by 2035 — How AI-Powered Sales Engagement Is Revolutionizing Revenue Operations
    • $50 Billion by 2035 — How RaaS Is Democratizing Automation for Enterprises of All Sizes
    • $12.5 Billion by 2035 — How Rugged Edge Computing Is Powering Industry 4.0

    About Us

    OmanNews.Club™ reports, publishes and aggregates business, Tech and lifestyle news on Oman the Middle East and the North Africa (MENA). 

    We provide press release distribution to media outlets in Oman, Arab countries and the (MENA) regions. Submit a press release or contact us today.

    Oman News is part of GroupWeb Media Network. @ 2026 GroupWeb Media LLC

    About Us / Contact Us / Submit News Release

    No Result
    View All Result
    • About Us
    • Cart
    • Checkout
    • Contact Us
    • Home
    • My account
    • Shop
    • Submit News Release
    • Test page

    Oman News is part of GroupWeb Media Network. @ 2026 GroupWeb Media LLC